Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Video: George Bakris, MD says over the next 3 years there is going to be an "explosion" in the number of studies we see in heart failure, diabetic kidney disease, and CV risk in general.

A new primary analysis found that the AstraZeneca and University of Oxford COVID-19 vaccine is safe and effective at preventing infection and reducing transmission.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Migraine headaches are a condition commonly seen in primary care. Here is a top-line look at the evidence for efficacy of the wide range of treatments available.

Hyaluronan represents a new class of biologic that significantly improves lung health in patients with severe COPD.

Opioids or opiate-like analgesics? Weight loss, exercise, or orthotics? Sleep interventions or cognitive therapy? What works for OA pain and what's the evidence?

Global confirmed cases of COVID-19 have surpassed 103 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Patients most often blame forgetfulness for not getting a second shot so reminders are key; just don't rely on a message via a patient portal to reach them.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Will desire to return to “normal” life propel patients to get a COVID-19 vaccine? What do they think about efforts to contain transmission? Answers and more insights here.

Director of the Brigham and Women's Diabetes Program Marie McDonnell, MD, talked with our editor about 2020 studies on SGLT-2 inhibitors, insulin icodec, and more.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Vaccines from both companies were significantly effective against COVID-19 and show promise against variants from the UK and South Africa.

In a phase 2/3 study, nearly half of rimegepant-treated patients demonstrated ≥50% reduction in the number of moderate-to-severe migraine days per month

US levels of SARS-CoV-2 circulation, associated illnesses, and deaths have been decreasing, but rising reporting delays due to holidays warrant caution.

The FDA approved vericiguat to reduce the risk of CV death and rehospitalization for HF in HF patients after hospital discharge or after outpatient treatment with IV diuretics.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

In episode 6 of Primary Viewpoints, physician mental health expert Michael Myers, MD, discusses the state of physician mental health during the COVID-19 pandemic.

The COVID-19 pandemic, says Dr Michael Myers, is an unprecedented environment for practicing medicine and for practitioners to effectively process daily experience.